Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 32 citing articles:

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 68
Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
Joseph T. Ortega, Beata Jastrzȩbska, Héctor R. Rangel
Pathogens (2021) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 60
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 12, pp. 1745-1758.e7
Open Access | Times Cited: 59
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 24
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 40
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
Cong Sun, Yinfeng Kang, Yuan-Tao Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants
Sabari Nath Neerukonda, Richard Wang, Russell Vassell, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 17
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Journal of Virology (2024)
Closed Access | Times Cited: 2
Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy
Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Antigenic Cartography Indicates That the Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 after Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
Ekaterina A. Astakhova, Alexei A. Morozov, Maria G. Byazrova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10493-10493
Open Access | Times Cited: 6
Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy
Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 9-9
Open Access | Times Cited: 15
Antigenic Cartography of SARS-CoV-2
Ekaterina A. Astakhova, Alexey A. Morozov, Julia D. Vavilova, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 5, pp. 862-871
Closed Access | Times Cited: 1
Antigenic Cartography Indicates That Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 After Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
Ekaterina A. Astakhova, Alexey A. Morozov, Maria G. Byazrova, et al.
(2023)
Open Access | Times Cited: 4
Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
25(OH)VitD and human endocrine and functional fertility parameters in women undergoing IVF/ICSI
Mei Tian, Suimin Zeng, Sufen Cai, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Agustı́n Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 5
Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines
Labanya Mukhopadhyay, Nivedita Gupta, Pragya D. Yadav, et al.
The Indian Journal of Medical Research (2022) Vol. 155, Iss. 1, pp. 105-122
Open Access | Times Cited: 4
Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022)
Rhys Parry, Youjun Shang, Julian D. J. Sng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Antigenic cartography of SARS-CoV-2 (review)
Ekaterina A. Astakhova, Alexey A. Morozov, Julia D. Vavilova, et al.
Биохимия (2024) Vol. 89, Iss. 5, pp. 843-853
Closed Access
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development
Xinkang Huan, Jiuyu Zhan, Hongwei Gao
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top